Financials
- Market Capitalization 1.62 B
- Employee 159
- Founded 1996
- CEO N/A
- Website www.inva.com
- Headquarter Delaware, United States
- FIGI BBG000CG9XT7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
3.72
ratio cours/chiffre d'affaires
4.69
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2128 | GHRS GH Research PLC - Ordinary Shares | 26.89 USD | +0.45% | -0.07% | +32.72% | +89.90% | 1.67 B USD | ||
| 2136 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.72 USD | +0.35% | -12.54% | -4.67% | +126.98% | 1.64 B USD | ||
| 2146 | VIR Vir Biotechnology, Inc. - Common Stock | 9.47 USD | -0.21% | -8.41% | +9.86% | +58.36% | 1.60 B USD | ||
| 2147 | ABSI Absci Corporation - Common Stock | 10.17 USD | -0.59% | -6.61% | +39.51% | +286.69% | 1.59 B USD |